Literature DB >> 15256776

Assessment of anxiety in subclinical thyroid disorders.

Mustafa Sait Gönen1, Gurcan Kisakol, Ali Savas Cilli, Oguz Dikbas, Kagan Gungor, Ali Inal, Ahmet Kaya.   

Abstract

It is well known that manifest thyroid dysfunction causes mood disorders. In the literature there are few studies related with subclinical thyroid dysfunction and anxiety. We aimed to determine if there exists a relation between the anxiety and subclinical thyroid dysfunction. This study was carried out in the Meram Medical Faculty of Selçuk University, Department of Endocrinology and Metabolism. Eighty-five outpatients were enrolled into the study. In the presence of normal fT(3) and fT(4), patients were grouped as subclinical hyperthyroid with TSH lower than 0.1 mU/L (n = 24), subclinical hypothyroid with TSH higher than 4.5 mU/L (n = 32) and euthyroid subjects (n = 29). Beck's Anxiety Inventory (BAI) was administered to all patients. There was no any statistically significant difference between euthyroid and study groups in terms of age, gender, weight and height (p<0.05). One-way ANOVA showed that both of the subclinical hypothyroid and subclinical hyperthyroid groups had significantly higher anxiety scores than euthyroid group (F: 11.4, p<0.001). Manifest hypothyroidism and hyperthyroidism, as causes of mental and neurological dysfunction have been known for a long time, but the relation between subclinical thyroid dysfunction and anxiety is less well studied. We have found that subclinical thyroid dysfunction increases the anxiety of patients whether hyperthyroid or hypothyroid. Overlap of symptoms common to both thyroid dysfunction and anxiety is an important limitation in this study. Mood changes especially anxiety due to subclinical thyroid dysfunction may have an important impact on the patient's quality of life. Negative effect on quality of life may be an indication of treatment in these patients. It is the first study evaluating anxiety in subclinical hypothyroidism in the literature.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256776     DOI: 10.1507/endocrj.51.311

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  10 in total

1.  Thyroid hormone regulation by stress and behavioral differences in adult male rats.

Authors:  Dana L Helmreich; Daniel Tylee
Journal:  Horm Behav       Date:  2011-06-12       Impact factor: 3.587

2.  Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients.

Authors:  Celestino Pio Lombardi; Raffaella Bocale; Angelina Barini; Antonella Barini; Annamaria D'Amore; Mauro Boscherini; Rocco Bellantone
Journal:  Endocrine       Date:  2016-07-07       Impact factor: 3.633

3.  Reversible changes in brain glucose metabolism following thyroid function normalization in hyperthyroidism.

Authors:  Q Miao; S Zhang; Y H Guan; H Y Ye; Z Y Zhang; Q Y Zhang; R D Xue; M F Zeng; C T Zuo; Y M Li
Journal:  AJNR Am J Neuroradiol       Date:  2011-05-19       Impact factor: 3.825

4.  Associations of Thyroid Hormones Profile During Normal Pregnancy and Postpartum With Anxiety, Depression, and Obsessive/Compulsive Disorder Scores in Euthyroid Women.

Authors:  Panagiota Konstantakou; Nikos Chalarakis; Georgios Valsamakis; Evangelos Grigoriou Sakkas; Eleni Vousoura; Alexandros Gryparis; Grigorios Evangelou Sakkas; George Papadimitriou; Ioannis Zervas; George Mastorakos
Journal:  Front Neurosci       Date:  2021-08-04       Impact factor: 4.677

5.  Prenatal thyroxine treatment disparately affects peripheral and amygdala thyroid hormone levels.

Authors:  Pradeep K Shukla; Laura J Sittig; Brian M Andrus; Daniel J Schaffer; Kanchi K Batra; Eva E Redei
Journal:  Psychoneuroendocrinology       Date:  2009-12-11       Impact factor: 4.905

6.  Health status, mood, and cognition in experimentally induced subclinical thyrotoxicosis.

Authors:  M H Samuels; K G Schuff; N E Carlson; P Carello; J S Janowsky
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

7.  Late pregnancy thyroid-binding globulin predicts perinatal depression.

Authors:  Cort Pedersen; Jane Leserman; Nacire Garcia; Melissa Stansbury; Samantha Meltzer-Brody; Jacqueline Johnson
Journal:  Psychoneuroendocrinology       Date:  2015-12-18       Impact factor: 4.905

8.  The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition.

Authors:  Mary H Samuels; Irina Kolobova; Anne Smeraglio; Dawn Peters; Jeri S Janowsky; Kathryn G Schuff
Journal:  J Clin Endocrinol Metab       Date:  2014-01-13       Impact factor: 5.958

9.  Treated Autoimmune Thyroid Disease Is Associated with a Decreased Quality of Life among Young Persons with Type 1 Diabetes.

Authors:  Alena Spirkova; Petra Dusatkova; Monika Peckova; Stanislava Kolouskova; Marta Snajderova; Barbora Obermannova; Katerina Stechova; Tamara Hrachovinova; Jiri Mares; Ondrej Cinek; Jan Lebl; Zdenek Sumnik; Stepanka Pruhova
Journal:  Int J Endocrinol       Date:  2015-05-18       Impact factor: 3.257

10.  The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma

Authors:  Nazli Gülsoy Kirnap; Özlem Turhan Iyidir; Yusuf Bozkuş; Şerife Mehlika Işildak; Cüneyd Anil; Sevde Nur Firat; Canan Demir; Asli Nar; Neslihan Başçil Tütüncü
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.